Determine Return on Investment in Heart Failure Remote Monitoring Program

Inclusion Criteria:

Absence of significant vision, hearing, or other communication deficits
English speaking;
Capable and willing to give informed consent;
Participated in the in-patient heart failure class within the last three months. Acceptable candidate for elective, non-emergent, remote monitoring as determined by ordering physician;
Living in a private home;
Hospital admission for Heart Failure or decompensation in the previous 12 months
New York Heart Association (NYHA) classes II-IV, as assigned by the nurse researcher, trained by a cardiologist
Cardiac aetiology: ischaemic, idiopathic, hypertensive, or valvular
Left ventricular ejection fraction <40% s an index of systolic dysfunction, combined or not with a left ventricular filling pattern supporting the presence of diastolic dysfunction, according to the American College of Cardiology/American Heart Association Guidelines for chronic heart failure.

or

NYHA class II-III who had an ejection fraction >40% and evidence of diastolic left ventricular dysfunction.
Optional subject with a diagnosis of diabetes (indicated by HbA1c >7).

Exclusion Criteria:

Currently involved in other investigational clinical trials (unless permission is granted by other study PI);
Females who are pregnant, planning to become pregnant within 3 months, or lactating;
Requirement for emergent placement other than private home (subject's condition would be compromised if there is a delay in placement).
Myocardial infarction, revascularization or Implantable Cardioverter Defibrillator (ICD) implantation in the previous 6 months angina or objective myocardial ischaemia requiring future revascularization implanted ventricular or atrial pacemaker (except dual chamber ICD pacemakers with good sinus activity);
End-stage heart failure requiring regular inotropic drug infusions;
Chronic renal failure requiring dialysis treatment and
Unstable angina.